Active Surveillance for Low-Risk PCa: Sprint or Marathon? Active Surveillance for Low-Risk PCa: Sprint or Marathon?
No easy algorithm for men who prefer to watch, rather than treat, their prostate cancers.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 5, 2024 Category: Cancer & Oncology Tags: Urology Source Type: news
FDA Drug Safety Communication: Ongoing Safety Review of GnRH Agonists and possible increased risk of diabetes and certain cardiovascular diseases
The U.S. Food and Drug Administration (FDA) is evaluating whether Gonadotropin-Releasing Hormone (GnRH) Agonists may increase the risk of diabetes and certain cardiovascular diseases (heart attack, sudden cardiac death, stroke) in men receiving these medications for the treatment of prostate cancer. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 4, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Daughter quits engineering for nursing after NHS successfully treats her dad's cancer
Chantel Ward, 47, had spent the last two decades working for an engineering company when she witnessed the care given to her father George as he needed treatment for prostate cancer during the Covid pandemic. (Source: Daily Express - Health)
Source: Daily Express - Health - January 2, 2024 Category: Consumer Health News Source Type: news
Vintage Philanthropy: Hollander Foundation Pours $20,000 into Prostate Cancer Research from Wine-Making Proceeds
Supported by non-profit wine making, The Hollander Foundation, committed to supporting prostate cancer research, awarded its annual gift to Eugene Shenderov, M.D. of Johns Hopkins University School of Medicine. Dr. Shenderov's lab focuses on the understanding of the mechanisms of the... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 2, 2024 Category: Pharmaceuticals Tags: NPT Source Type: news
BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution form
It is a more patient-friendly way to tackle prostate cancer. It can help improve patient compliance to a great extent, Badiger said. The company said introducing the Drug Controller General of India (DCGI)approved new drug delivery system will make it more affordable and accessible in India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 2, 2024 Category: Pharmaceuticals Source Type: news
Receipt of Novel Hormonal Therapy for Advanced Prostate Cancer Varies With Race
THURSDAY, Dec. 28, 2023 -- For Medicare beneficiaries with advanced prostate cancer (PCa), receipt of novel hormonal therapy (NHT) agents varies with race, according to a study published online Dec. 1 in JAMA Network Open.
Ting Martin Ma, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 28, 2023 Category: Pharmaceuticals Source Type: news
Racial, ethnic representation increases over time in NCDB
Representation of Hispanic and American Indian or Alaska Native individuals in the National Cancer Database (NCDB) has increased over time, according to research published December 27 in JAMA Network Open.
A team led by Yasoda Satpathy from University of California, San Diego found in a study of more than 5 million individuals who were diagnosed with breast, colorectal, lung, and prostate cancer that while these groups were undercaptured in the database, their representation improved over time.
“An understanding of the limitations of the NCDB, including limited representation of Hispanic and American Indian or Alaska N...
Source: AuntMinnie.com Headlines - December 28, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: Womens Imaging Source Type: news
Hispanic, Indigenous Americans Undercaptured in National Cancer Database
WEDNESDAY, Dec. 27, 2023 -- Hispanic and American Indian or Alaska Native (AI/AN) individuals diagnosed with breast, colorectal, lung, and prostate cancer have been undercaptured in the National Cancer Database (NCDB), but their representation is... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 27, 2023 Category: Pharmaceuticals Source Type: news
Testosterone for Hypogonadism Cleared So Far of Prostate Cancer Risk
(MedPage Today) -- Men treated with testosterone replacement therapy (TRT) for hypogonadism didn't have an increase in adverse prostate events, the TRAVERSE trial found.
Over a mean follow-up of 33 months, those who used topical 1.62% testosterone... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 27, 2023 Category: Hematology Source Type: news
Thousands of men with advanced prostate cancer to be offered pill which lowers risk of death by a third
Thousands of men with advanced prostate cancer are set to be offered a pill which can lower the risk of death by a third. Experts claim olaparib offers a lifeline to men with the disease. (Source: the Mail online | Health)
Source: the Mail online | Health - December 23, 2023 Category: Consumer Health News Source Type: news
‘I went to see my GP to stop smoking and found out I had prostate cancer’
Professional darts player, Martin Adams, also known as ‘ Wolfie', had no idea what prostate cancer was when he found out he had the disease. (Source: Daily Express - Health)
Source: Daily Express - Health - December 21, 2023 Category: Consumer Health News Source Type: news
Podcast: Why medical students should choose radiology
AuntMinnie.com · Keeping Up With The Radiologists - Episode 1: Why medical students should choose radiologyWhy should medical students choose radiology? In their inaugural episode of the "Keeping Up With the Radiologists" podcast series brought to you by AuntMinnie.com in collaboration with Penn Radiology, Saurabh (Harry) Jha, MD, and Mitch Schnall, MD, PhD, of the University of Pennsylvania speak with medical student Michael Duong, PhD, about his choice, and also discuss current trends and issues affecting the practice of radiology.Jha offers insights cropped out of his early experiences in Britain and Australia, immersi...
Source: AuntMinnie.com Headlines - December 20, 2023 Category: Radiology Authors: Liz Carey Tags: Artificial Intelligence Medical Students Source Type: news
MRI comparable to Ga-68 PSMA PET/CT for prostate cancer diagnosis
MRI performs comparably to Gallium-68 (Ga-68) PSMA PET/CT for prostate cancer diagnosis and treatment tracking, according to research delivered at the recent RSNA meeting."68Ga PSMA PET/CT and prostate MRI may be complementary in both initial diagnosis and therapy planning, including guiding radiation where it may be the appropriate therapeutic approach," presenter Sean Gharai, MD, of Georgetown University in Washington, DC, and colleagues noted. Gharai shared the research on November 26.Ga-68 PSMA PET/CT imaging has been used mainly to assess prostate cancer's response to initial treatment with surgery or radiation therap...
Source: AuntMinnie.com Headlines - December 20, 2023 Category: Radiology Authors: Kate Madden Yee Tags: Subspecialties Genitourinary Radiology Source Type: news
MRI comparable to 68Ga PSMA PET/CT for prostate cancer diagnosis
MRI performs comparably to 68Ga PSMA PET/CT for prostate cancer diagnosis and treatment tracking, according to research delivered at the recent RSNA meeting."68Ga PSMA PET/CT and prostate MRI may be complementary in both initial diagnosis and therapy planning, including guiding radiation where it may be the appropriate therapeutic approach," presenter Sean Gharai, MD, of Georgetown University in Washington, DC, and colleagues noted. Gharai shared the research on November 26.68Ga PSMA PET/CT imaging has been used mainly to assess prostate cancer's response to initial treatment with surgery or radiation therapy, according to...
Source: AuntMinnie.com Headlines - December 20, 2023 Category: Radiology Authors: Kate Madden Yee Tags: Subspecialties Genitourinary Radiology Source Type: news
Almost 40,000 men at high-risk of prostate cancer have now taken vital 30-second checks via Paddy Power's big-money sponsorship of the Ally Pally World Darts Championship
A total of 48,728 people have now completed Prostate Cancer UK's online checker since November 30, five times higher than during the same time period last year. (Source: the Mail online | Health)
Source: the Mail online | Health - December 19, 2023 Category: Consumer Health News Source Type: news
